ABVC Mentioned in Globe Investor Marketwire Report
Feb 2, 2009

The Atlanic BioVenture Centre was acknowleged by PharmEng CEO Alan Kwong (TSX: PII) as a strategic project partner in Keata Pharma's recently funded "Daffodil Derived Galanthamine for Alzheimers Disease Initiative" proposal.

See the report in Globe Investor Online:

http://www.globeinvestor.com/servlet/story/CCNM.20090130.509254_1/GIStory/
  News
Jun 8, 2010 Progress Magazine -
Mar 10, 2010 NSAC Researchers reducing greenhouse gas emissions
Mar 8, 2010 Stirling Pharma Inc. takes over North Sydney drug plant
Mar 1, 2010 "Going Carbon Mootral" details the value of garlic in reducing greenhouse gas emissions
Jan 25, 2010 Governments of Canada and Nova Scotia Announce Major Investment of $7 Million for Agricultural Innov...
Oct 1, 2009 Adding Value - New agriculture centre in Bible Hill would help boost local economy
Feb 2, 2009 ABVC Mentioned in Globe Investor Marketwire Report
Jan 23, 2009 ABVC affiliate Keata Pharma Awarded $3.0Million from ACOA AIF
Jan 1, 2009 Atlantic BioVenture Centre CEO Dr. Richard Ablett speaks on CBC Radio about value of Innovative Micr...
Nov 1, 2008 CoRda Acknowledges ABVC's regional Contribution During Launch of New Website
Jun 6, 2008 Atlantic BioVenture Centre Holds Open House for Microfactory Project
Dec 1, 2007 ABVC & AAFC Invest in Development of Portable Modular Micro-factory for on farm processing
Feb 1, 2007 ABVC CEO Dr. Richard Ablett Invterviewed and Quoted in Atlantic Business Magazine
Mar 31, 2006 ABVC Awarded $2.9 million from ACOA AIF (New Wealth from Atlantic Bio-Resources)

Home  |   Our Story  |   What We Do  |   Project Pipeline  |   Meet Our Team  |   Newsroom  |   Contact Us  |   Site Map

©2008 Atlantic BioVenture Centre
Website by Cossette East